TAIPEI (TVBS News) — Intuitive Surgical, Inc. has received clearance from the Taiwan Food and Drug Administration (TFDA) for its innovative da Vinci SP surgical system. This state-of-the-art technology allows surgeons to conduct precise operations via a single, small incision, representing a major leap forward in Taiwan's minimally invasive surgical capabilities.
The da Vinci SP system is engineered with a single SP arm, allowing for flexible port placement. This sophisticated design integrates three multi-jointed instruments and a fully wristed 3D HD camera through one cannula, aiming to improve precision and patient outcomes. Jason Yang, Intuitive Taiwan's vice president and general manager, reiterated the company's patient-centered mission during the da Vinci SP launch event on Monday (May 5), emphasizing their dedication to innovation and expressing satisfaction in introducing this cutting-edge system to Taiwan.
Intuitive is set to broaden its minimally invasive surgery offerings in Taiwan, aiming to establish a robust ecosystem for training and education that will support surgeons and hospitals. The da Vinci SP system is internationally recognized, having obtained clearance from the U.S. Food and Drug Administration and CE mark approval in Europe, underscoring its global acceptance and dependability.
Based in Sunnyvale, California, Intuitive is a global titan in minimally invasive care and robotic-assisted surgery, leveraging over 20 years of expertise. The company made its direct mark in Taiwan in 2019, having previously facilitated access to its technology through distributors since the inaugural da Vinci-assisted surgery in Taipei in 2004.
As Intuitive advances its technological frontiers, the release of the da Vinci SP system in Taiwan is poised to transform the healthcare landscape significantly. Surgeons and hospitals in the region stand to gain considerably from this innovative technology, promising enhancements in patient care and surgical outcomes. ★